Benin Management Corp Abbott Laboratories Transaction History

Benin Management Corp

$354 Million
Q3 2024

A detailed history of Benin Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Benin Management Corp holds 9,047 shares of ABT stock, worth $1.06 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

9,047

Previous 8,964 0.93%

Holding current value

$1.06 Million

Previous $931,000 10.74%

% of portfolio

0.29%

Previous 0.28%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $8,305 - $9,804	83 Added 0.93%	9,047 $1.03 Million
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $10,375 - $11,581	-103 Reduced 1.14%	8,964 $931,000
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $438 - $483	4 Added 0.04%	9,067 $1.03 Million
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $22,096 - $27,048	-245 Reduced 2.63%	9,063 $997,000
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $955 - $1,146	-10 Reduced 0.11%	9,308 $901,000
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $388,204 - $432,541	-3,852 Reduced 29.25%	9,318 $1.02 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $9,686 - $11,401	-100 Reduced 0.75%	13,170 $1.33 Million
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $9,676 - $11,203	-100 Reduced 0.75%	13,270 $1.28 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $11,227 - $13,570	-110 Reduced 0.82%	13,370 $1.45 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $137,480 - $168,337	-1,190 Reduced 8.11%	13,480 $1.9 Million
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $3,849 - $4,258	-33 Reduced 0.22%	14,670 $1.73 Million
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $642,156 - $756,556	-5,900 Reduced 28.64%	14,703 $1.76 Million
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $199,500 - $217,398	-1,900 Reduced 8.44%	20,603 $2.26 Million
Q3 2020 Oct 22, 2020	SELL	$91.64 - $111.29 $203,899 - $247,620	-2,225 Reduced 9.0%	22,503 $2.45 Million
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $137,826 - $176,400	-1,800 Reduced 6.79%	24,728 $2.26 Million
Q1 2020 Apr 20, 2020	SELL	$62.82 - $91.86 $18,846 - $27,558	-300 Reduced 1.12%	26,528 $2.09 Million
Q4 2019 Jan 23, 2020	SELL	$78.51 - $87.4 $43,965 - $48,944	-560 Reduced 2.04%	26,828 $2.33 Million
Q3 2019 Oct 22, 2019	SELL	$81.84 - $88.74 $20,460 - $22,185	-250 Reduced 0.9%	27,388 $2.29 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $103,270 - $120,445	-1,417 Reduced 4.88%	27,638 $2.32 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $536,382 - $648,486	-8,100 Reduced 21.8%	29,055 $2.32 Million
Q3 2018 Oct 17, 2018	SELL	$60.81 - $73.36 $15,202 - $18,340	-250 Reduced 0.67%	37,155 $2.73 Million
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $997,385 - $1.13 Million	-17,725 Reduced 32.15%	37,405 $2.24 Million
Q4 2017 Jan 18, 2018	SELL	$53.68 - $57.47 $2.19 Million - $2.34 Million	-40,725 Reduced 42.49%	55,130 $3.15 Million
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $4.61 Million - $5.14 Million	95,855	95,855 $5.12 Million

Others Institutions Holding ABT

# of Institutions

3,173

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.

Account

Benin Management Corp Abbott Laboratories Transaction History